New York State Common Retirement Fund
MPLT

New York State Common Retirement Fund’s MapLight Therapeutics MPLT Stock Holding History

New York State Common Retirement Fund’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$190K Hold
5,300
– – ﹤0.01% 2392
2026
Q1 		$108K Hold
5,300
– – ﹤0.01% 2490
2025
Q4 		$93.1K Buy
+5,300
New +$88.8K ﹤0.01% 2636

Other funds holding MPLT

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MSWMA
Market Street Wealth Management Advisors Indianapolis, Indiana $703M AUM 16.2% 1-Year Est. Return
MPW
MA Private Wealth San Carlos, California $671M AUM 23.37% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

New York State Common Retirement Fund's MPLT Position: Q2 2026 in Review

New York State Common Retirement Fund held its MapLight Therapeutics (MPLT) position steady in Q2 2026 at 5,300 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

New York State Common Retirement Fund first reported a position in MPLT in Q4 2025 and has held it in 3 quarters since. 18 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • New York State Common Retirement Fund held 5,300 shares of MapLight Therapeutics worth $190K as of Q2 2026.
  • New York State Common Retirement Fund left its MapLight Therapeutics share count unchanged in Q2 2026.
  • MapLight Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2392 holding.
  • New York State Common Retirement Fund first reported a position in MapLight Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 18 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.